Retraction: MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway

Xiao-Ping Wang; Jian Zhou; Ming Han; Chuan-Bao Chen; Yi-Tao Zheng; Xiao-Shun He; Xiao-Peng Yuan

doi:10.18632/oncotarget.28676

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway

PDF | How to cite

Oncotarget. 2024; 15:814-814. https://doi.org/10.18632/oncotarget.28676

Metrics: PDF 162 views | ?

Xiao-Ping Wang^1,*, Jian Zhou^1,*, Ming Han¹, Chuan-Bao Chen¹, Yi-Tao Zheng¹, Xiao-Shun He¹ and Xiao-Peng Yuan¹

¹Third Division of Organ Transplant Center, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510700, P. R. China
^*These authors contributed equally to this work

Published: November 22, 2024

Copyright: © 2024 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Corresponding author Xiao-Peng Yuan contacted Oncotarget and stated there are ‘major flaws’ in the paper. Oncotarget requested that the Academic Committee at Sun Yat-sen University review this paper. Finally, the Supervision Committee of the National Natural Science Foundation of China reviewed the paper. This review discovered problems, such as writing by a third-party company for investment, false signature, and unauthorized marking of the National Natural Science Foundation of China project number. The corresponding author Yuan Xiaopeng is responsible for the above problems. In addition, Yuan Xiaopeng included this paper in his application for the National Natural Science Foundation of China (application number 8177030286), and he should also be responsible for the objective results of false information in the application. In addition, Figure 11B contains numerous image duplications with Figure 12B of [1], which has since been retracted. Except the corresponding author, all other authors were unable to be reached. Therefore, the Editorial decision was made to retract the paper.

REFERENCES

1. Zhang ZF, Wang YJ, Fan SH, Du SX, Li XD, Wu DM, Lu J, Zheng YL. MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9. Oncotarget. 2017; 8:101345–61. https://doi.org/10.18632/oncotarget.21167. [PubMed]. Retraction in: Oncotarget. 2022; 13:1003. https://doi.org/10.18632/oncotarget.28269. [PubMed]

Original article: Oncotarget. 2017; 8:13264–13276. DOI: https://doi.org/10.18632/oncotarget.14807.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28676

Publication Alerts

Post-Publication Promotion

Publication Discount

Retraction:

Retraction: MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway